Skip to main content
TipRanks
Go Ultimate75% OFF

Avalo Therapeutics (AVTX) Revenue

1,100 Followers

Avalo Therapeutics Revenue

Revenue (ttm)
59.00K
Revenue Growth
-69.27%
P/S Ratio
7017.17
Revenue/Employee
$1,788
Employees
33
Market Cap
$414.01M

Revenue Chart

Avalo Therapeutics Revenue - Annual

05M10M15M20M25M30M27.81M18.33M6.75M6.70M5.40M18.05M1.92M441.00K59.00K201720182019202020212022202320242025
Revenue History
Download to Excel
AVTX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202559.00K-382.00K-86.62%
Dec 31, 2024441.00K-1.48M-77.08%
Dec 31, 20231.92M-16.13M-89.34%
Dec 31, 202218.05M12.65M234.40%
Dec 31, 20215.40M-1.30M-19.42%
Dec 31, 20206.70M-51.35K-0.76%
Dec 31, 20196.75M-11.58M-63.17%
Dec 31, 201818.33M-9.49M-34.11%
Dec 31, 201727.81M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
AVTX59.00K
CRBP0.00
MIST2.34M
ELTX0.00
GUTS0.00